Literature DB >> 7653093

Quantification of individual subgenomic mRNA species during replication of the coronavirus transmissible gastroenteritis virus.

J A Hiscox1, D Cavanagh, P Britton.   

Abstract

A biotinylated-oligonucleotide-based method was used to isolate the subgenomic mRNAs of the coronavirus transmissible gastroenteritis virus (TGEV) to investigate the amounts of the mRNAs produced at early, middle and late times in the replication cycle. TGEV mRNA 6, which encodes the N protein, was observed to be the most abundant species throughout the replication cycle. The ratios of mRNA 6 to the other mRNAs were 1:0.11 (mRNA 2), 1:0.16 (mRNAs 3 and 4) and 1:0.37 (mRNA 5) at 12 h post-infection. All the mRNA species were differentially regulated throughout the replication cycle, although the rate of accumulation of mRNAs 4, 5 and 6, but not mRNA 3, increased markedly towards the end of the replication cycle. mRNA 7 was not detected in the system used. There was no observable correlation between the amounts of each mRNA synthesised and the potential degree of base pairing between the 3' end of the leader sequence and the transcription associated sequences on the genomic RNA at any time during the replication cycle. This indicates that the extent of base pairing was not the only factor involved in the control of subgenomic mRNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7653093      PMCID: PMC7134076          DOI: 10.1016/0168-1702(94)00108-o

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  26 in total

1.  Minus-strand copies of replicating coronavirus mRNAs contain antileaders.

Authors:  P B Sethna; M A Hofmann; D A Brian
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

2.  Mechanism of coronavirus transcription: duration of primary transcription initiation activity and effects of subgenomic RNA transcription on RNA replication.

Authors:  Y S Jeong; S Makino
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate.

Authors:  J P Chamberlain
Journal:  Anal Biochem       Date:  1979-09-15       Impact factor: 3.365

4.  In vitro replication of mouse hepatitis virus strain A59.

Authors:  S R Compton; D B Rogers; K V Holmes; D Fertsch; J Remenick; J J McGowan
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

5.  Intracellular RNAs of the feline infectious peritonitis coronavirus strain 79-1146.

Authors:  R J de Groot; R J ter Haar; M C Horzinek; B A van der Zeijst
Journal:  J Gen Virol       Date:  1987-04       Impact factor: 3.891

6.  Coronavirus transcription: subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis.

Authors:  S G Sawicki; D L Sawicki
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

7.  Propagation of the virus of porcine epidemic diarrhea in cell culture.

Authors:  M Hofmann; R Wyler
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

8.  Sequence of the nucleoprotein gene from a virulent British field isolate of transmissible gastroenteritis virus and its expression in Saccharomyces cerevisiae.

Authors:  P Britton; R S Cármenes; K W Page; D J Garwes; F Parra
Journal:  Mol Microbiol       Date:  1988-01       Impact factor: 3.501

9.  The cloning and sequencing of the virion protein genes from a British isolate of porcine respiratory coronavirus: comparison with transmissible gastroenteritis virus genes.

Authors:  P Britton; K L Mawditt; K W Page
Journal:  Virus Res       Date:  1991-11       Impact factor: 3.303

10.  Analysis of a 9.6 kb sequence from the 3' end of canine coronavirus genomic RNA.

Authors:  B C Horsburgh; I Brierley; T D Brown
Journal:  J Gen Virol       Date:  1992-11       Impact factor: 3.891

View more
  26 in total

1.  The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus.

Authors:  J A Hiscox; T Wurm; L Wilson; P Britton; D Cavanagh; G Brooks
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale Immunity.

Authors:  Mark Yarmarkovich; John M Warrington; Alvin Farrel; John M Maris
Journal:  SSRN       Date:  2020-04-14

3.  Insertion of a new transcriptional unit into the genome of mouse hepatitis virus.

Authors:  B Hsue; P S Masters
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  Differentiation between human coronaviruses NL63 and 229E using a novel double-antibody sandwich enzyme-linked immunosorbent assay based on specific monoclonal antibodies.

Authors:  Patricia Sastre; Ronald Dijkman; Ana Camuñas; Tamara Ruiz; Maarten F Jebbink; Lia van der Hoek; Carmen Vela; Paloma Rueda
Journal:  Clin Vaccine Immunol       Date:  2010-11-17

5.  Heterologous gene expression from transmissible gastroenteritis virus replicon particles.

Authors:  Kristopher M Curtis; Boyd Yount; Ralph S Baric
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Seroprevalence of turkey coronavirus in North American turkeys determined by a newly developed enzyme-linked immunosorbent assay based on recombinant antigen.

Authors:  Maged H Gomaa; Dongwan Yoo; Davor Ojkic; John R Barta
Journal:  Clin Vaccine Immunol       Date:  2008-10-29

7.  Investigation of the control of coronavirus subgenomic mRNA transcription by using T7-generated negative-sense RNA transcripts.

Authors:  J A Hiscox; K L Mawditt; D Cavanagh; P Britton
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

Review 8.  Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Authors:  Vincent C C Cheng; Susanna K P Lau; Patrick C Y Woo; Kwok Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

9.  The nucleocapsid protein of human coronavirus NL63.

Authors:  Kaja Zuwała; Anna Golda; Wojciech Kabala; Michał Burmistrz; Michal Zdzalik; Paulina Nowak; Sylwia Kedracka-Krok; Mirosław Zarebski; Jerzy Dobrucki; Dominik Florek; Sławomir Zeglen; Jacek Wojarski; Jan Potempa; Grzegorz Dubin; Krzysztof Pyrc
Journal:  PLoS One       Date:  2015-02-20       Impact factor: 3.240

10.  A rapid point of care immunoswab assay for SARS-CoV detection.

Authors:  Sriram Kammila; Dipankar Das; Pravin K Bhatnagar; Hoon H Sunwoo; Gustavo Zayas-Zamora; Malcolm King; Mavanur R Suresh
Journal:  J Virol Methods       Date:  2008-07-11       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.